Haemonetics (HAE) has redrawn its business map by merging its Plasma and Blood Center units into a single Apheresis segment ...

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 4:00 PM EDTCompany ParticipantsChristopher Simon ...

Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced an update to its reportable ...

South Korea is one of the few countries considered to have controlled hypertension thanks to concerted policy over the past 15 years. Faith McLellan reports.

Haemonetics gains attention after softer earnings highlighted the impact of unusual accounting items and long-term healthcare ...

Shares of blood products company Haemonetics (NYSE:HAE) jumped 4.1% in the afternoon session after BofA Securities upgraded its rating on the company to Buy from Neutral and raised its price target to ...

Aristotle Capital Boston, LLC, an investment advisor, released its first-quarter 2026 investor letter for “Small Cap Equity Fund”. A copy of the letter is available to download here. U.S. small-cap ...

Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies ...

Haemonetics reported a Q4 adjusted EPS of $1.29, beating the forecast of $1.27. Revenue for Q4 reached $346 million, surpassing expectations by 2.66%. The stock surged by 9.51% in pre-market trading ...

Blood products company Haemonetics (NYSE:HAE). reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 4.8% year on year to $346.4 million. Its non-GAAP profit of $1.29 per ...